Nigeria
· Delayed Price · Currency is NGN Pharma Deko Statistics
Total Valuation
Pharma Deko has a market cap or net worth of NGN 396.98 million.
| Market Cap | 396.98M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharma Deko has 216.93 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 216.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| PB Ratio | 0.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.21 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.66 |
| Interest Coverage | -13.37 |
Financial Efficiency
Return on equity (ROE) is -11.45% and return on invested capital (ROIC) is -6.55%.
| Return on Equity (ROE) | -11.45% |
| Return on Assets (ROA) | -3.65% |
| Return on Capital (ROIC) | -6.55% |
| Revenue Per Employee | 6.71M |
| Profits Per Employee | -2.02M |
| Employee Count | 70 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Deko had revenue of NGN 469.58 million and -141.61 million in losses. Loss per share was -0.65.
| Revenue | 469.58M |
| Gross Profit | 34.37M |
| Operating Income | -132.32M |
| Pretax Income | -141.61M |
| Net Income | -141.61M |
| EBITDA | -63.29M |
| EBIT | -132.32M |
| Loss Per Share | -0.65 |
Balance Sheet
The company has 9.21 million in cash and 31.78 million in debt, giving a net cash position of -22.57 million or -0.10 per share.
| Cash & Cash Equivalents | 9.21M |
| Total Debt | 31.78M |
| Net Cash | -22.57M |
| Net Cash Per Share | -0.10 |
| Equity (Book Value) | 1.17B |
| Book Value Per Share | 5.38 |
| Working Capital | -764.13M |
Cash Flow
In the last 12 months, operating cash flow was -43.85 million and capital expenditures -4.47 million, giving a free cash flow of -48.32 million.
| Operating Cash Flow | -43.85M |
| Capital Expenditures | -4.47M |
| Free Cash Flow | -48.32M |
| FCF Per Share | -0.22 |
Margins
Gross margin is 7.32%, with operating and profit margins of -28.18% and -30.16%.
| Gross Margin | 7.32% |
| Operating Margin | -28.18% |
| Pretax Margin | -30.16% |
| Profit Margin | -30.16% |
| EBITDA Margin | -13.48% |
| EBIT Margin | -28.18% |
| FCF Margin | -10.29% |
Dividends & Yields
Pharma Deko does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -35.67% |
| FCF Yield | -12.17% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma Deko has an Altman Z-Score of -0.86. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.86 |
| Piotroski F-Score | n/a |